Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,481 across all filing types
Latest filing 2026-01-22 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Donev investments holding" AD for rights received for the issue of warrants with ISIN ąBG4000002262 as of 19.01.2026
Director's Dealing Classification · 100% confidence The document is explicitly titled 'NOTIFICATION OF INSIDERS' TRANSACTIONS' and references 'art. 19 of Regulation 596/2014' (MAR - Market Abuse Regulation), which governs the reporting of transactions by persons discharging managerial responsibilities. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2026-01-22 English
Notification from "Donev investments holding" rights received for the issue of warrants with ISIN ą BG4000001264 as of 19.01.2026
Director's Dealing Classification · 100% confidence The document is a standard notification form for transactions by persons discharging managerial responsibilities (PDMR) and persons closely associated with them, as required by Article 19 of the EU Market Abuse Regulation (MAR) 596/2014. It explicitly identifies the person (Donev Investments Holding AD), the issuer (Sopharma AD), and the nature of the transaction (receipt of rights for warrants). This falls under the category of Director's Dealing (DIRS).
2026-01-22 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the percentage of share capital, the total value, and the resulting balance of treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-22 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It explicitly details the number of shares sold, the percentage of share capital, the total value, and the resulting balance of treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-21 English
Sales revenues for December 2025
Earnings Release Classification · 95% confidence The document is a short notification (690 characters) issued by 'Sopharma' AD regarding monthly and annual sales performance figures. It is not a full financial report, but rather a brief announcement of key performance highlights (sales growth percentages). As it provides specific financial highlights for a period without being a full quarterly or annual report, and fits the description of an initial announcement of results, it is classified as an Earnings Release. FY 2025
2026-01-20 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a formal notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the transaction date, the price, and the resulting change in the company's treasury share holdings. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.